The Risk of Immune-Mediated Skin Disease Under Dipeptidyl-Peptidase IV Inhibitor: A Global Population-Based Study

Noor Mruwat, Noga Givon-Lavi, Ralf J. Ludwig, Khalaf Kridin

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	International Journal of Dermatology
DOIs	https://doi.org/10.1111/ijd.17923
State	Accepted/In press - 2025
Externally published	Yes

Keywords

@article{28a586046c2d473899530cfeb342d5bc,

title = "The Risk of Immune-Mediated Skin Disease Under Dipeptidyl-Peptidase IV Inhibitor: A Global Population-Based Study",

keywords = "SGLT-2, autoimmune skin diseases, dipeptidyl-peptidase IV inhibitor, thiazolidinedione",

author = "Noor Mruwat and Noga Givon-Lavi and Ludwig, \{Ralf J.\} and Khalaf Kridin",

year = "2025",

doi = "10.1111/ijd.17923",

language = "אנגלית",

journal = "International Journal of Dermatology",

issn = "0011-9059",

publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - The Risk of Immune-Mediated Skin Disease Under Dipeptidyl-Peptidase IV Inhibitor

T2 - A Global Population-Based Study

AU - Mruwat, Noor

AU - Givon-Lavi, Noga

AU - Ludwig, Ralf J.

AU - Kridin, Khalaf

PY - 2025

Y1 - 2025

KW - SGLT-2

KW - autoimmune skin diseases

KW - dipeptidyl-peptidase IV inhibitor

KW - thiazolidinedione

UR - https://www.scopus.com/pages/publications/105009830187

U2 - 10.1111/ijd.17923

DO - 10.1111/ijd.17923

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:105009830187

SN - 0011-9059

JO - International Journal of Dermatology

JF - International Journal of Dermatology

ER -